Suna Ertok, MD

Suna Ertok, MD is a Nuclear Medicine specialist at Acibadem Eskisehir Hospital in Eskişehir, where she works in the Nuclear Medicine unit. Her practice covers both diagnostic and therapeutic nuclear medicine, with a particular focus on scintigraphic and SPECT imaging. She has more than 33 years in medicine and consults in Turkish and English.

Dr. Ertok studied at Osmangazi University Faculty of Medicine from 1993 to 1999 and completed her specialty training in Nuclear Medicine at the same faculty between 1999 and 2003; her education record also lists Nuclear Medicine at Osmangazi University Faculty of Medicine in 2008. During her training years, from 1999 to 2003, she also worked at Sivrihisar 1 No”lu 112 Emergency Aid and Rescue Station. From 2008 to 2010 she worked in the Department of Nuclear Medicine at Isparta Devlet Hospital, and in 2011 she joined Acıbadem Healthcare Services. She is a member of the Eskişehir Medical Chamber and the Turkish Nuclear Medicine Association.

Clinical focus

Dr. Ertok’s clinical work centers on diagnostic nuclear medicine and therapeutic nuclear medicine. On the imaging side, her areas of expertise include bone scintigraphy, Tc-99m MDP scintigraphy and Tc-99m MIBI SPECT imaging. These examinations use small amounts of radioactive tracers to show how tissues and organs function, and they are generally interpreted together with the patient’s history, clinical examination and other imaging or laboratory findings. Whether a particular nuclear medicine study is appropriate for an individual patient is decided case by case, taking the clinical question and any previous tests into account.

The conditions listed among her areas of expertise include cutaneous melanoma, metastatic inguinal lymph node and lung carcinoma. Her published work reflects these interests. She co-authored a report in Clinical Nuclear Medicine (November 2007) describing cutaneous melanoma with extraosseous accumulation of Tc-99m MDP in a metastatic inguinal lymph node on bone scintigraphy, and a study in the Journal of Computer Assisted Tomography (September/October 2007) examining Tc-99m MIBI SPECT imaging in patients with lung carcinoma and the question of whether it can serve as a functional probe of multidrug resistance genes.

How Dr. Ertok works with international patients

Dr. Ertok consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit itself. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options, including whether a nuclear medicine study or treatment is relevant to the patient’s situation. Video consultation is available for international patients who wish to discuss their case with Dr. Ertok before deciding whether to travel.